(Q44252551)

1 December 2017

title

Effects of fexofenadine on the early response to nasal allergen challenge (English)

1 reference

1 December 2017

Frances T Allocco

1

1 reference

1 December 2017

Virginia Votypka

2

1 reference

1 December 2017

Marcy deTineo

3

1 reference

1 December 2017

Robert M Naclerio

4

1 reference

1 December 2017

Fuad M Baroody

5

1 reference

1 December 2017

publication date

1 December 2002

1 reference

Annals of Allergy, Asthma & Immunology

1 December 2017

published in

1 reference

1 December 2017

volume

89

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

578-584

1 reference

Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Cardiovascular safety of fexofenadine HCl.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

The effect of terfenadine on unilateral nasal challenge with allergen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Clinical pharmacology of new histamine H1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Effect of oxymetazoline on the early response to nasal challenge with antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Effects of loratadine and terfenadine on the induced nasal allergic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

The effect of cetirizine on early allergic response

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

The role of leukotrienes in allergic rhinitis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

The effect of azelastine on the early allergic response

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

Inhibition of potassium-induced release of histamine from mast cells by tetraethylammonium and tetramethylammonium

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962105-9

7 January 2021

10.1016/S1081-1206(10)62105-9

Identifiers

DOI

1 reference

1 December 2017

1 reference